F692-0410 Screening compound: N~2~-{[1-(4-chlorobenzyl)-4-piperidyl]methyl}-7,8-dimethyl-4-oxo-4H-[1,3]thiazino[3,2-a][1,3]benzimidazole-2-carboxamide

F692-0410 Screening compound: N~2~-{[1-(4-chlorobenzyl)-4-piperidyl]methyl}-7,8-dimethyl-4-oxo-4H-[1,3]thiazino[3,2-a][1,3]benzimidazole-2-carboxamide
F692-0410 Screening compound: N~2~-{[1-(4-chlorobenzyl)-4-piperidyl]methyl}-7,8-dimethyl-4-oxo-4H-[1,3]thiazino[3,2-a][1,3]benzimidazole-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F692-0410
N~2~-{[1-(4-chlorobenzyl)-4-piperidyl]methyl}-7,8-dimethyl-4-oxo-4H-[1,3]thiazino[3,2-a][1,3]benzimidazole-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F692-0410

Molecular Formula

C26H27ClN4O2S (C26 H27 ClN4 O2 S)

Compound Name

N~2~-{[1-(4-chlorobenzyl)-4-piperidyl]methyl}-7,8-dimethyl-4-oxo-4H-[1,3]thiazino[3,2-a][1,3]benzimidazole-2-carboxamide

IUPAC name

N-({1-[(4-chlorophenyl)methyl]piperidin-4-yl}methyl)-45-dimethyl-13-oxo-10-thia-18-diazatricyclo[7.4.0.0^{27}]trideca-246811-pentaene-11-carboxamide

SMILES

Cc(c(C)c1)cc(n23)c1nc3SC(C(NCC1CCN(Cc(cc3)ccc3Cl)CC1)=O)=CC2=O

InChI

InChI=1S/C26H27ClN4O2S/c1-16-11-21-22(12-17(16)2)31-24(32)13-23(34-26(31)29-21)25(33)28-14-18-7-9-30(10-8-18)15-19-3-5-20(27)6-4-19/h3-6,11-13,18H,7-10,14-15H2,1-2H3,(H,28,33)

InChI Key

UKGZQEQPSILZKV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14963848

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

495.04

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.989

Distribution Coefficient, logD

3.352

Water Solubility, LogSw

-5.02

Polar Surface Area

52.782

Acid Dissociation Constant (pKa)

13.35

Base Dissociation Constant (pKb)

9.03

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

34.60

F692-0410 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

DGK Inhibitors Library (10558 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F692-0410 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F692-0410?
Check Price and Availability of F692-0410, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F692-0410 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F692-0410
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F692-0410
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F692-0410 available by request